How Much Did Ultrahuman Raise? Funding & Key Investors

What Is Ultrahuman?

Ultrahuman, founded in 2019, is a health and fitness technology company based in Bangalore, Karnataka, India. The company operates in multiple industries, including biotechnology, clinical trials, fitness, health care, and wellness.

Ultrahuman offers a range of products designed to track and enhance various aspects of health. Their offerings include advanced wearable devices like the Ultrahuman Ring AIR, blood testing services through Blood Vision, and continuous glucose monitoring with the M1 CGM sensor.

How Much Funding Has Ultrahuman Raised?

1. Seed Round
   • Amount Raised: USD 7,500,000
   • Date: 2019
   • Lead Investors: Nexus Venture Partners, Blume Ventures
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To secure initial capital for product development and market entry.
2. Series A
   • Amount Raised: USD 17,500,000
   • Date: August 2021
   • Lead Investors: Alpha Wave Incubation (AWI)
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To develop and market wearable health monitoring products including the CGM sensor and Ring.
3. Angel Round
   • Amount Raised: Not publicly disclosed
   • Date: May 2022
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support ongoing growth and product expansion.
4. Series B
   • Amount Raised: USD 35,000,000 (USD 25,000,000 equity + USD 10,000,000 debt)
   • Date: March 2024
   • Lead Investors: Blume Ventures, Steadview Capital, Nexus Venture Partners
   • Valuation at Round: Approximately USD 125,000,000
   • Motivation Behind the Round: To expand manufacturing capabilities and conduct more in-depth health-tracking research.
5. Venture Debt
   • Amount Raised: INR 1,000,000,000 (~USD 11,300,000)
   • Date: November 2025
   • Lead Investors: Alteria Capital
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support market expansion, sports and research partnerships, and new software revenue streams.
6. Series C
   • Amount Raised: INR 4,000,000,000 (~USD 48,000,000)
   • Date: March 2026
   • Lead Investors: Not publicly confirmed (Premji Invest was reported by sources as lead, but denied by CEO Mohit Kumar; lead investor undisclosed)
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand global wearables business and scale operations.

Total Amount Raised: At least USD 119,300,000 based on disclosed funding (Seed: $7.5M + Series A: $17.5M + Series B: $35M + Venture Debt Nov 2025: ~$11.3M + Series C: ~$48M; Angel Round amount undisclosed).

Current Valuation: Not publicly disclosed

Key Investors

• Alteria Capital
  • Details: Alteria Capital is a venture debt fund that provides structured debt solutions to high-growth startups in India. They led the ₹100 crore venture debt round for Ultrahuman in November 2025.
  • Investment Focus Areas: Technology, healthcare, consumer services.
  • Notable Investments: Ultrahuman, Dunzo, Lendingkart.
• Steadview Capital
  • Details: Steadview Capital is an investment firm focusing on long-term investments in public and private companies. They participated in Ultrahuman's Series A and co-led the Series B round.
  • Investment Focus Areas: Technology, healthcare, financial services.
  • Notable Investments: Ultrahuman, Nykaa, Zomato.
• Blume Ventures
  • Details: Blume Ventures is a venture capital firm investing in early-stage startups. They participated from the Seed round and co-led the Series B funding round in March 2024.
  • Investment Focus Areas: Technology, healthcare, consumer services.
  • Notable Investments: Ultrahuman, Unacademy, Dunzo.
• Nexus Venture Partners
  • Details: Nexus Venture Partners is a venture capital firm investing in early and growth-stage companies. They have participated in multiple Ultrahuman funding rounds from Seed through Series B.
  • Investment Focus Areas: Technology, consumer services, healthcare.
  • Notable Investments: Ultrahuman, Delhivery, Druva.
• Alpha Wave Incubation (AWI)
  • Details: Alpha Wave Incubation is a global investment firm backed by DisruptAD and managed by Falcon Edge. They led Ultrahuman's Series A round in August 2021 and participated in subsequent rounds.
  • Investment Focus Areas: Technology, healthcare, consumer services.
  • Notable Investments: Ultrahuman, Swiggy, Razorpay.
• Rainmatter Capital
  • Details: Rainmatter Capital is the venture capital arm of Zerodha, India's largest retail stockbroker, focused on health, fintech, and climate sectors. They are among the disclosed equity investors in Ultrahuman.
  • Investment Focus Areas: Fintech, health, climate.
  • Notable Investments: Ultrahuman, Nirog Street, Smallcase.

What's Next for Ultrahuman?

Ultrahuman stands at the cusp of significant growth opportunities. With plans to expand manufacturing capabilities and delve deeper into health-tracking research, the company is poised to capture a larger market share in the wearable health tech industry. The potential to surpass $100 million in annualized revenue by the end of 2024 underscores the vast market potential.

Future fundraising rounds, including potential Series C funding, could further bolster Ultrahuman's expansion and technological advancements. Strategic investments or partnerships with larger health-tech companies may also be on the horizon, providing additional avenues for growth.

However, challenges such as increasing losses and stiff competition from global players like Levels Health and Oura could pose hurdles. Maintaining profitability while scaling operations and ensuring the accuracy of health monitoring devices will be crucial for sustained success.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Ultrahuman and gather other critical business insights.

Sign up for free to start making data-driven decisions and stay ahead in the competitive market.